Please use this identifier to cite or link to this item:
Title: Infliximab-induced psoriasis during therapy for Crohn's disease
Authors: STEINWURZ, FlavioDENADAI, RafaelSAAD-HOSSNE, RogerioQUEIROZ, Maria LuizaTEIXEIRA, Fabio VieiraROMITI, Ricardo
Citation: JOURNAL OF CROHNS & COLITIS, v.6, n.5, p.610-616, 2012
Abstract: Although therapy with tumor necrosis factor-alpha inhibitors (anti-TNF) provides beneficial effects in different immune inflammatory disorders, paradoxical cases of anti-THE-induced psoriasis have increasingly been reported, mostly in the setting of rheumatologic diseases. To date, less than 50 cases of infliximab-induced psoriasis in inflammatory bowel disease patients have been described. The present report was aimed at describing two new cases of infliximab-induced psoriasis during therapy for Crohn's disease and at carrying out a review on this intriguing phenomenon.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Files in This Item:
File Description SizeFormat 
  Restricted Access
publishedVersion (English)613.32 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.